Nabla Raises $70M Series C to Enhance Clinical AI

Nabla, a leading AI assistant in clinical care, has successfully raised $70 million in a Series C funding round led by HV Capital and supported by Highland Europe, DST Global, existing investor Cathay Innovation, and Tony Fadell's Build Collective. This effort elevates the company's total raised capital to $120 million. Nabla aims to enhance their clinical AI capabilities to optimize both clinical and financial workflows across multiple care settings, guided by their mission of reinstating the human touch in healthcare practices. Having already gained trust from over 130 healthcare organizations and 85,000 clinicians, Nabla plans to use the new funds to expedite product development, grow technical and go-to-market teams, and forge strategic partnerships. The expansion includes the deployment of agentic AI capabilities to support coding and Electronic Health Records (EHR) functionalities, adjusting across diverse clinical roles for more effective streamlining and measurable ROI. Globally, Nabla is highly regarded for its integration with major EHRs and its focus on a privacy-first model, processing over 30 billion tokens monthly. With its expanded functionalities, Nabla seeks to become a proactive AI assistant, driving wise efficiencies within complex clinical settings.